Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yagi

Showing results (401-410 of 461) with videos related to

Pageof 47
Sort By:
Molecular Pharmacology|January 1, 1981
Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymesM Nordqvist, D R Thakker, K P Vyas, et al.
Biochimica Et Biophysica Acta|September 11, 1996
Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitroY Mizushina, N Tanaka, H Yagi, et al.
International Journal of Hematology|December 10, 1998
Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregationK Makita, T Shimoyama, Y Sakurai, et al.
Cancer Research|July 1, 1979
Carcinogenicity of 2-hydroxybenzo(a)pyrene and 6-hydroxybenzo(a)pyrene in newborn miceR L Chang, P G Wislocki, J Kapitulnik, et al.
The Journal of Biological Chemistry|September 25, 1984
Effects of a 6-fluoro substituent on the metabolism of benzo(a)pyrene 7,8-dihydrodiol to bay-region diol epoxides by rat liver enzymesD R Thakker, H Yagi, J M Sayer, et al.
Molecular Pharmacology|January 1, 1979
Metabolism of benzo[a]anthracene to its tumorigenic 3,4-dihydrodiolD R Thakker, W Levin, H Yagi, et al.
Cancer Research|September 1, 1976
Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cellsP G Wislocki, A W Wood, R L Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Evaluation of preoperative chemotherapy for colorectal cancer]G Nishimura, Y Michiwa, H Yagi, et al.
Biochemical and Biophysical Research Communications|October 10, 1977
High mutageniticity of metabolically activated chrysene 1,2 dihydrodiol: evidence for bay region activation of chryseneA W Wood, W Levin, D Ryan, et al.
Molecular Pharmacology|November 1, 1977
Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positionsA W Wood, W Levin, A Y Lu, et al.
Pageof 47

Showing results (401-410 of 461) with videos related to

Sort By:
Pageof 47
Molecular Pharmacology|January 1, 1981
Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymesM Nordqvist, D R Thakker, K P Vyas, et al.
Biochimica Et Biophysica Acta|September 11, 1996
Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitroY Mizushina, N Tanaka, H Yagi, et al.
International Journal of Hematology|December 10, 1998
Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregationK Makita, T Shimoyama, Y Sakurai, et al.
Cancer Research|July 1, 1979
Carcinogenicity of 2-hydroxybenzo(a)pyrene and 6-hydroxybenzo(a)pyrene in newborn miceR L Chang, P G Wislocki, J Kapitulnik, et al.
The Journal of Biological Chemistry|September 25, 1984
Effects of a 6-fluoro substituent on the metabolism of benzo(a)pyrene 7,8-dihydrodiol to bay-region diol epoxides by rat liver enzymesD R Thakker, H Yagi, J M Sayer, et al.
Molecular Pharmacology|January 1, 1979
Metabolism of benzo[a]anthracene to its tumorigenic 3,4-dihydrodiolD R Thakker, W Levin, H Yagi, et al.
Cancer Research|September 1, 1976
Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cellsP G Wislocki, A W Wood, R L Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Evaluation of preoperative chemotherapy for colorectal cancer]G Nishimura, Y Michiwa, H Yagi, et al.
Biochemical and Biophysical Research Communications|October 10, 1977
High mutageniticity of metabolically activated chrysene 1,2 dihydrodiol: evidence for bay region activation of chryseneA W Wood, W Levin, D Ryan, et al.
Molecular Pharmacology|November 1, 1977
Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positionsA W Wood, W Levin, A Y Lu, et al.
Pageof 47